Utilization of the Behavior Change Wheel framework to develop a model to improve cardiometabolic screening for people with severe mental illness

Implementation Science

Volumn 12, Issue 1, 2017, Pages

  Mangurian, Christina ^a,b   Niu, Grace C ^a   Schillinger, Dean ^b,c   Newcomer, John W ^d   Dilley, James ^a   Handley, Margaret A ^b,c,e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Center for Vulnerable Populations   (United States)

^c UCSF Department of Medicine   (United States)

^d FLORIDA ATLANTIC UNIVERSITY   (United States)

^e UCSF Department of Epidemiology and Biostatistics   (United States)

Author keywords

Behavior change wheel; Cardiometabolic screening; Severe mental illness

Indexed keywords

ATTITUDE TO HEALTH; CARDIOVASCULAR DISEASE; HEALTH PERSONNEL ATTITUDE; HUMAN; INFORMATION PROCESSING; MENTAL DISEASE; MENTAL HEALTH SERVICE; METABOLIC DISORDER; MOTIVATION; ORGANIZATION AND MANAGEMENT; PREVENTIVE MEDICINE; PRIMARY HEALTH CARE; PSYCHIATRY; PSYCHOLOGICAL MODEL; SEVERITY OF ILLNESS INDEX;

ATTITUDE OF HEALTH PERSONNEL; CARDIOVASCULAR DISEASES; COMMUNITY MENTAL HEALTH SERVICES; FOCUS GROUPS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MENTAL DISORDERS; METABOLIC DISEASES; MODELS, PSYCHOLOGICAL; MOTIVATION; PREVENTIVE MEDICINE; PRIMARY HEALTH CARE; PSYCHIATRY; SEVERITY OF ILLNESS INDEX;

EID: 85034032274     PISSN: None     EISSN: 17485908     Source Type: Journal    
DOI: 10.1186/s13012-017-0663-z     Document Type: Article

References (94)

1. Colton CW, Manderscheid RW. Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states. Prev Chronic Dis. 2006;3(2):A42.
2. Olfson M, Gerhard T, Huang C, Crystal S, Stroup T. Premature mortality among adults with schizophrenia in the united states. JAMA Psychiat. 2015;72(12):1172-81. doi: 10.1001/jamapsychiatry.2015.1737.
3. Newcomer JW. Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review. CNS Drugs. 2005;19(Suppl 1):1-93.
4. American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists, North American Association for the Study of Obesity. Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care. 2004;27(2):596-601. https://www.ncbi.nlm.nih.gov/pubmed/14747245.
5. Giorda C, Picariello R, Nada E, Tartaglino B, Marafetti L, Costa G, et al. The impact of adherence to screening guidelines and of diabetes clinics referral on morbidity and mortality in diabetes. PLoS One. 2012;7(4):e33839.
6. Mitchell A, Delaffon V, Vancampfort D, Correll C, De Hert M. Guideline concordant monitoring of metabolic risk in people treated with antipsychotic medication: systematic review and meta-analysis of screening practices. Psychol Med. 2012;42(01):125-47.
7. Burton A, Osborn D, Atkins L, Michie S, Gray B, Stevenson F, et al. Lowering cardiovascular disease risk for people with severe mental illnesses in primary care: a focus group study. PLoS One. 2015;10(8):e0136603.
8. Krein SL, Bingham CR, McCarthy JF, Mitchinson A, Payes J, Valenstein M. Diabetes treatment among VA patients with comorbid serious mental illness. Psychiatr Serv. 2006;57(7):1016-21. doi: 10.1176/appi.ps.57.7.1016.
9. Piette JD, Heisler M, Ganoczy D, McCarthy JF, Valenstein M. Differential medication adherence among patients with schizophrenia and comorbid diabetes and hypertension. Psychiatr Serv. 2007;58(2):207-12. doi: 10.1176/appi.ps.58.2.207.
10. Kreyenbuhl J, Dixon LB, McCarthy JF, Soliman S, Ignacio RV, Valenstein M. Does adherence to medications for type 2 diabetes differ between individuals with vs without schizophrenia? Schizophr Bull. 2010;36(2):428-35. doi: 10.1093/schbul/sbn106.
11. Osborn D, Burton A, Walters K, Nazareth I, Heinkel S, Atkins L, et al. Evaluating the clinical and cost effectiveness of a behaviour change intervention for lowering cardiovascular disease risk for people with severe mental illnesses in primary care (PRIMROSE study): study protocol for a cluster randomised controlled trial. Trials. 2016;17(1):1.
12. AHRQ review finds evidence of the effectiveness of collaborative care interventions. Psychiatr Serv. 2012;63(10):1055. doi: 10.1176/appi.ps.1012.
13. Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the global burden of disease study 2010. Lancet. 2012;380(9859):2197-223. doi: 10.1016/S0140-6736(12)61689-4.
14. Katon WJ. Clinical and health services relationships between major depression, depressive symptoms, and general medical illness. Biol Psychiatry. 2003;54(3):216-26.
15. Keyes CL. Promoting and protecting mental health as flourishing: a complementary strategy for improving national mental health. Am Psychol. 2007;62(2):95-108. doi: 10.1037/0003-066X.62.2.95.
16. Kessler RC, Berglund PA, Bruce ML, Koch JR, Laska EM, Leaf PJ, et al. The prevalence and correlates of untreated serious mental illness. Health Serv Res. 2001;36(6 Pt 1):987-1007.
17. Bauer AM. Review: collaborative care improves depression and anxiety symptoms in adults. Evid Based Ment Health. 2013;16(2):40. doi: 10.1136/eb-2012-101139.
18. Gilbody S, Bower P, Fletcher J, Richards D, Sutton AJ. Collaborative care for depression: a cumulative meta-analysis and review of longer-term outcomes. Arch Intern Med. 2006;166(21):2314-21. doi: 10.1001/archinte.166.21.2314.
19. Medicine Io. The National Academies Collection: reports funded by National Institutes of Health. Improving the quality of health care for mental and substance-use conditions: quality chasm series. Washington (DC): National Academies Press (US) National Academy of Sciences; 2006.
20. Newcomer JW, Hennekens CH. Severe mental illness and risk of cardiovascular disease. JAMA. 2007;298(15):1794-6. https://doi.org/10.1001/jama.298.15.1794.
21. Chwastiak LA, Rosenheck RA, Kazis LE. Utilization of primary care by veterans with psychiatric illness in the National Department of Veterans Affairs Health Care System. J Gen Intern Med. 2008;23(11):1835-40. doi: 10.1007/s11606-008-0786-7.
22. Copeland LA, Zeber JE, Wang CP, Parchman ML, Lawrence VA, Valenstein M, et al. Patterns of primary care and mortality among patients with schizophrenia or diabetes: a cluster analysis approach to the retrospective study of healthcare utilization. BMC Health Serv Res. 2009;9:127. doi: 10.1186/1472-6963-9-127.
23. Druss BG, von Esenwein SA, Compton MT, Rask KJ, Zhao L, Parker RM. A randomized trial of medical care management for community mental health settings: the primary care access, referral, and evaluation (PCARE) study. Am J Psychiatry. 2010;167(2):151-9. doi: 10.1176/appi.ajp.2009.09050691.
24. Berren MR, Santiago JM, Zent MR, Carbone CP. Health care utilization by persons with severe and persistent mental illness. Psychiatr Serv. 1999;50(4):559-61.
25. Alakeson V, Frank RG, Katz RE. Specialty care medical homes for people with severe, persistent mental disorders. Health Aff (Millwood). 2010;29(5):867-73. doi: 10.1377/hlthaff.2010.0080.
26. Druss BG, Marcus SC, Campbell J, Cuffel B, Harnett J, Ingoglia C, et al. Medical services for clients in community mental health centers: results from a national survey. Psychiatr Serv. 2008;59(8):917-20. doi: 10.1176/appi.ps.59.8.917.
27. Collins C, Hewson DL, Munger R, Wade T. Evolving models of behavioral health integration in primary care. New York: Milbank Memorial Fund; 2010.
28. Khaykin E, Eaton WW, Ford DE, Anthony CB, Daumit GL. Health insurance coverage among persons with schizophrenia in the United States. Psychiatr Serv. 2010;61(8):830-4. doi: 10.1176/appi.ps.61.8.830.
29. Substance Abuse and Mental Health Services Administration. Health homes and medical homes. 2017. https://www.integration.samhsa.gov/integrated-care-models/health-homes. Accessed 8 Nov 2017.
30. Zung WW, Broadhead WE, Roth ME. Prevalence of depressive symptoms in primary care. J Fam Pract. 1993;37(4):337-44.
31. Katon W, Von Korff M, Lin E, Lipscomb P, Russo J, Wagner E, et al. Distressed high utilizers of medical care. DSM-III-R diagnoses and treatment needs. Gen Hosp Psychiatry. 1990;12(6):355-62.
32. Agency for Health Care Policy and Research DGP. Depression in primary care: treatment of major depression. Rockville: U.S. Department of Health and Human Services; 1993.
33. Pincus HA, Pettit AR. The societal costs of chronic major depression. J Clin Psychiatry. 2001;62(Suppl 6):5-9.
34. McEvoy JP, Meyer JM, Goff DC, Nasrallah HA, Davis SM, Sullivan L, et al. Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the clinical antipsychotic trials of intervention effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III. Schizophr Res. 2005;80(1):19-32. doi: 10.1016/j.schres.2005.07.014.
35. Kelly DL, McMahon RP, Wehring HJ, Liu F, Mackowick KM, Boggs DL, et al. Cigarette smoking and mortality risk in people with schizophrenia. Schizophr Bull. 2011;37(4):832-8. doi: 10.1093/schbul/sbp152.
36. James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the eighth joint national committee (jnc 8). JAMA. 2014;311(5):507-20. doi: 10.1001/jama.2013.284427.
37. Stone NJ, Robinson JG, Lichtenstein AH, Merz CNB, Blum CB, Eckel RH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;63(25_PA):2889-934.
38. American Diabetes Association. Standards of medical care in diabetes-2016. Diabetes Care. 2016;39(Supplement 1):S1-S109.
39. Kreyenbuhl J, Buchanan RW, Dickerson FB, Dixon LB. The schizophrenia patient outcomes research team (PORT): updated treatment recommendations 2009. Schizophr Bull. 2010;36(1):94-103. doi: 10.1093/schbul/sbp130.
40. Hogan P, Dall T, Nikolov P. Economic costs of diabetes in the US in 2002. Diabetes Care. 2003;26(3):917-32.
41. Schneiderhan ME, Batscha CL, Rosen C. Assessment of a point-of-care metabolic risk screening program in outpatients receiving antipsychotic agents. Pharmacotherapy. 2009;29(8):975-87. doi: 10.1592/phco.29.8.975.
42. Thompson A, Hetrick SE, Álvarez-Jiménez M, Parker AG, Willet M, Hughes F, et al. Targeted intervention to improve monitoring of antipsychotic-induced weight gain and metabolic disturbance in first episode psychosis. Aust N Z J Psychiatry. 2011;45(9):740-8.
43. Velligan DI, Castillo D, Lopez L, Manaugh B, Davis C, Rodriguez J, et al. A case control study of the implementation of change model versus passive dissemination of practice guidelines for compliance in monitoring for metabolic syndrome. Community Ment Health J. 2013;49(2):141-9.
44. Kreyenbuhl J, Dixon LB, Brown CH, Medoff DR, Klingaman EA, Fang LJ, et al. A randomized controlled trial of a patient-centered approach to improve screening for the metabolic side effects of antipsychotic medications. Community Ment Health J. 2017;53(2):163-75. https://www.ncbi.nlm.nih.gov/pubmed/27061185.
45. Barnes T, Paton C, Hancock E, Cavanagh M, Taylor D, Lelliott P, on behalf of the UK Prescribing Observatory for Mental Health. Screening for the metabolic syndrome in community psychiatric patients prescribed antipsychotics: a quality improvement programme. Acta Psychiatr Scand. 2008;118(1):26-33.
46. Reilly S, Planner C, Gask L, Hann M, Knowles S, Druss B, et al. Collaborative care approaches for people with severe mental illness. Cochrane Database Syst Rev. 2013;(11):CD009531. https://www.ncbi.nlm.nih.gov/pubmed/24190251.
47. Scharf DM EN, Hackbarth NS, Horvitz-Lennon M, Beckman R, Han B, Lovejoy SL, Pincus HA, Burnam MA. Evaluation of the SAMHSA Primary and Behavioral Health Care Integration (PBHCI) Grant Program: final report (task 13) 2014.
48. Bradford DW, Cunningham NT, Slubicki MN, McDuffie JR, Kilbourne AM, Nagi A, et al. An evidence synthesis of care models to improve general medical outcomes for individuals with serious mental illness: a systematic review. J Clin Psychiatry. 2013;74(8):e754-64.
49. Cabassa LJ, Stefancic A, O'Hara K, El-Bassel N, Lewis-Fernández R, Luchsinger JA, et al. Peer-led healthy lifestyle program in supportive housing: study protocol for a randomized controlled trial. Trials. 2015;16(1):1.
50. Cabassa LJ, Camacho D, Velez-Grau CM, Stefancic A. Peer-based health interventions for people with serious mental illness: a systematic literature review. J Psychiatr Res. 2016;84:80-9.
51. Druss BG, Silke A, Compton MT, Zhao L, Leslie DL. Budget impact and sustainability of medical care management for persons with serious mental illnesses. Am J Psychiatry. 2011;168(11):1171-8. https://www.ncbi.nlm.nih.gov/pubmed/21676993.
52. DelMonte M, Bostwick J, Bess J, Dalack G. Evaluation of a computer-based intervention to enhance metabolic monitoring in psychiatry inpatients treated with second-generation antipsychotics. J Clin Pharm Ther. 2012;37(6):668-73.
53. Gilmer TP, O'Connor PJ, Sperl-Hillen JM, Rush WA, Johnson PE, Amundson GH, et al. Cost-effectiveness of an electronic medical record based clinical decision support system. Health Serv Res. 2012;47(6):2137-58.
54. O'Connor PJ, Sperl-Hillen JM, Rush WA, Johnson PE, Amundson GH, Asche SE, et al. Impact of electronic health record clinical decision support on diabetes care: a randomized trial. Ann Fam Med. 2011;9(1):12-21. doi: 10.1370/afm.1196.
55. Ramanuj PP. Improving blood and ECG monitoring among patients prescribed regular antipsychotic medications. Ment Health Fam Med. 2013;10(1):29.
56. Boulware LE, Daumit GL, Frick KD, Minkovitz CS, Lawrence RS, Powe NR. An evidence-based review of patient-centered behavioral interventions for hypertension. Am J Prev Med. 2001;21(3):221-32.
57. Daumit GL, Dickerson FB, Wang NY, Dalcin A, Jerome GJ, Anderson CA, et al. A behavioral weight-loss intervention in persons with serious mental illness. N Engl J Med. 2013;368(17):1594-602. doi: 10.1056/NEJMoa1214530.
58. Druss BG, von Esenwein SA, Glick GE, Deubler E, Lally C, Ward MC, et al. Randomized trial of an integrated behavioral health home: the health outcomes management and evaluation (HOME) study. Am J Psychiatr. 2016; doi: 10.1176/appi.ajp.2016.16050507.
59. Alexander L, Druss B. Behavioral health homes for people with mental health and substance use conditions: the core clinical features. Washington: SAMHSA-HRSA Center for Integrated Health Solutions, US Department of Health and Human Services; 2012.
60. Smith TE, Sederer LIA. New kind of homelessness for individuals with serious mental illness? The need for a "mental health home". Psychiatr Serv. 2009;60(4):528-33.
61. Scharf DM, Eberhart NK, Schmidt N, Vaughan CA, Dutta T, Pincus HA, et al. Integrating primary care into community behavioral health settings: programs and early implementation experiences. Psychiatr Serv. 2013;64(7):660-5. https://www.ncbi.nlm.nih.gov/pubmed/23584674.
62. Michie S, van Stralen MM, West R. The behaviour change wheel: a new method for characterising and designing behaviour change interventions. Implement Sci. 2011;6:42. doi: 10.1186/1748-5908-6-42.
63. Michie S, Johnston M, Abraham C, Lawton R, Parker D, Walker A. Making psychological theory useful for implementing evidence based practice: a consensus approach. Qual Saf Health Care. 2005;14(1):26-33. doi: 10.1136/qshc.2004.011155.
64. Cane J, O'Connor D, Michie S. Validation of the theoretical domains framework for use in behaviour change and implementation research. Implement Sci. 2012;7(1):37.
65. Ajzen I. The theory of planned behavior. Organ Behav Hum Decis Process. 1991;50(2):179-211.
66. Godin G, Kok G. The theory of planned behavior: a review of its applications to health-related behaviors. Am J Health Promot. 1996;11(2):87-98.
67. Atkins L, Francis J, Islam R, O'Connor D, Patey A, Ivers N, et al. A guide to using the theoretical domains framework of behaviour change to investigate implementation problems. Implement Sci. 2017;12(1):77. doi: 10.1186/s13012-017-0605-9.
68. Colquhoun HL, Squires JE, Kolehmainen N, Fraser C, Grimshaw JM. Methods for designing interventions to change healthcare professionals' behaviour: a systematic review. Implement Sci. 2017;12(1):30.
69. Porcheret M, Main C, Croft P, McKinley R, Hassell A, Dziedzic K. Development of a behaviour change intervention: a case study on the practical application of theory. Implement Sci. 2014;9(1):42.
70. French SD, Green SE, O'Connor DA, McKenzie JE, Francis JJ, Michie S, et al. Developing theory-informed behaviour change interventions to implement evidence into practice: a systematic approach using the theoretical domains framework. Implement Sci. 2012;7(1):38.
71. Foy R, Francis JJ, Johnston M, Eccles M, Lecouturier J, Bamford C, et al. The development of a theory-based intervention to promote appropriate disclosure of a diagnosis of dementia. BMC Health Serv Res. 2007;7(1):207.
72. Kolehmainen N, Francis JJ. Specifying content and mechanisms of change in interventions to change professionals' practice: an illustration from the good goals study in occupational therapy. Implement Sci. 2012;7(1):100.
73. Taylor N, Lawton R, Slater B, Foy R. The demonstration of a theory-based approach to the design of localized patient safety interventions. Implement Sci. 2013;8(1):123.
74. Patey AM, Islam R, Francis JJ, Bryson GL, Grimshaw JM. Anesthesiologists' and surgeons' perceptions about routine pre-operative testing in low-risk patients: application of the Theoretical Domains Framework (TDF) to identify factors that influence physicians' decisions to order pre-operative tests. Implement Sci. 2012;7(1):52.
75. Squires JE, Suh KN, Linklater S, Bruce N, Gartke K, Graham ID, et al. Improving physician hand hygiene compliance using behavioural theories: a study protocol. Implement Sci. 2013;8(1):16.
76. Liang L, Bernhardsson S, Vernooij RW, Armstrong MJ, Bussières A, Brouwers MC, et al. Use of theory to plan or evaluate guideline implementation among physicians: a scoping review. Implement Sci. 2017;12(1):26.
77. Cabassa LJ, Druss B, Wang Y, Lewis-Fernández R. Collaborative planning approach to inform the implementation of a healthcare manager intervention for Hispanics with serious mental illness: a study protocol. Implement Sci. 2011;6(1):80.
78. Bauer MS, McBride L, Williford WO, Glick H, Kinosian B, Altshuler L, et al. Collaborative care for bipolar disorder: part II. Impact on clinical outcome, function, and costs. Psychiatr Serv. 2006;57(7):937-45. doi: 10.1176/ps.2006.57.7.937.
79. Mangurian C, Modlin C, Williams L, Essock SM, Riano NS, Shumway M et al. A doctor is in the house: stakeholder focus groups about expanded scope of practice of community psychiatrists. Community Ment Health J. in press.
80. Mangurian C, Newcomer JW, Vittinghoff E, Creasman JM, Knapp P, Fuentes-Afflick E, et al. Diabetes screening among underserved adults with severe mental illness who take antipsychotic medications. JAMA Intern Med. 2015;175(12):1977-9. doi: 10.1001/jamainternmed.2015.6098.
81. Morrato EH, Druss BG, Hartung DM, Valuck RJ, Thomas D, Allen R, et al. Small area variation and geographic and patient-specific determinants of metabolic testing in antipsychotic users. Pharmacoepidemiol Drug Saf. 2011;20(1):66-75. doi: 10.1002/pds.2062.
82. Druss BG, von Esenwein SA. Improving general medical care for persons with mental and addictive disorders: systematic review. Gen Hosp Psychiatry. 2006;28(2):145-53. doi: 10.1016/j.genhosppsych.2005.10.006.
83. Amiel JM, Pincus HA. The medical home model: new opportunities for psychiatric services in the United States. Curr Opin Psychiatry. 2011;24(6):562-8. doi: 10.1097/YCO.0b013e32834baa97.
84. Miller CJ, Grogan-Kaylor A, Perron BE, Kilbourne AM, Woltmann E, Bauer MS. Collaborative chronic care models for mental health conditions: cumulative meta-analysis and metaregression to guide future research and implementation. Med Care. 2013;51(10):922-30. doi: 10.1097/MLR.0b013e3182a3e4c4.
85. Bodenheimer T, Wagner EH, Grumbach K. Improving primary care for patients with chronic illness. JAMA. 2002;288(14):1775-9.
86. Rosenthal TC. The medical home: growing evidence to support a new approach to primary care. J Am Board Fam Med. 2008;21(5):427-40.
87. Bower P, Gilbody S. Stepped care in psychological therapies: access, effectiveness and efficiency. Br J Psychiatry. 2005;186(1):11-7.
88. Richardson WC, Berwick DM, Bisgard J, Bristow L, Buck C, Cassel C. Crossing the quality chasm: a new health system for the 21st century. Washington, DC: Institute of Medicine, National Academy Press; 2001.
89. Hoffmann TC, Glasziou PP, Boutron I, Milne R, Perera R, Moher D, et al. Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide. BMJ. 2014;348:g1687.
90. Unutzer J, Katon W, Callahan CM, Williams JW Jr, Hunkeler E, Harpole L, et al. Collaborative care management of late-life depression in the primary care setting: a randomized controlled trial. JAMA. 2002;288(22):2836-45.
91. McAlpine DD, Mechanic D. Utilization of specialty mental health care among persons with severe mental illness: the roles of demographics, need, insurance, and risk. Health Serv Res. 2000;35(1 Pt 2):277.
92. Sniehotta FF, Presseau J, Araújo-Soares V. Time to retire the theory of planned behaviour: Taylor & Francis. Health Psychol Rev. 2014;8(1):1-7. https://www.ncbi.nlm.nih.gov/pubmed/25053004.
93. Glasgow RE, Vogt TM, Boles SM. Evaluating the public health impact of health promotion interventions: the RE-AIM framework. Am J Public Health. 1999;89(9):1322-7.
94. Damschroder LJ, Aron DC, Keith RE, Kirsh SR, Alexander JA, Lowery JC. Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implement Sci. 2009;4(1):50.